EUVIMEDEUVIMED entdecken
Multizentrische Studie

Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome

Marie-Sophie Pagniez iD, Victor Fages, Clémence Gatinois, Romain Larrue, Nicolas Pottier, Timothée Laboux, Rémi Lenain, Olivier Grunewald, Thomas Robert iD, Claire Rigothier, Laurent Mesnard iD, François Glowacki

Nephrology Dialysis Transplantation · 01.08.2025 · 40 (8) · 1522-1530

DOI: 10.1093/ndt/gfaf011 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 14.01.2025. Verfasst von Marie-Sophie Pagniez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kidney Transplantation and Dialysis, CHU Lille, University of Lille, Lille, France. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Collagen Type IV, Exons, Glycine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Unlike X-linked or autosomal recessive Alport syndrome, no clear genotype/phenotype correlation has yet been demonstrated in patients carrying a single variant of COL4A3 or COL4A4.

Methods

We carried out a multicentre retrospective study to assess the risk factors involved in renal survival in patients presenting a single pathogenic variant on COL4A3 or COL4A4.

Results

A total of 97 patients presenting a single pathogenic variant of COL4A3 or COL4A4 were included. The prevalence of end-stage kidney disease (ESKD) during follow-up was 28.7% [median age 47.5 years (interquartile range 39.1–55.8). A total of 23 patients carried a ‘severe’ mutation (frameshift, stop gain, extensive deletion, impacting splicing) and 60 patients presented a glycine substitution in a collagenous domain. In patients with glycine missense variants, the location of the mutation in the distal exons was associated with worse renal survival with a more pronounced decline in the estimated glomerular filtration rate compared with variants in proximal exons. Conversely, the presence of a severe mutation did not impact renal survival.

Conclusion

Our results confirm that autosomal dominant Alport syndrome (ADAS) can lead to ESKD. We demonstrated that a glycine substitution involving the distal exons had a negative impact on renal survival in ADAS patients, probably due to a trimerization defect. This could help improve personalized follow-up in ADAS patients with glycine substitution and could be integrated into a future prognostic score to accurately predict renal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryCollagen Type IVExonsGlycineKidney Failure, ChronicAutoantigensMutationHumansMaleFemaleAdultRetrospective StudiesMiddle AgedGlomerular Filtration RateFollow-Up StudiesPrognosisSurvival RateRisk Factors

Stichwörter der Autor:innen

COL4A3COL4A4autosomal dominant Alport syndromecollagen IVglycine substitution

Substanzen

Collagen Type IVGlycinetype IV collagen alpha3 chainAutoantigensCOL4A4 protein, human

Autor:innen und Institutionen

  • Department of Nephrology, Kidney Transplantation and Dialysis, CHU Lille, University of Lille, Lille, France.
  • Department of Nephrology, Transplantation, Dialysis and Apheresis, CHU Bordeaux, Bordeaux, France.
  • University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, Toxicology and Genetic Diseases Department, CHU Lille, Lil…
  • Department of Nephrology and Kidney Transplantation, Conception Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Service de Soins Intensifs Néphrologiques et Rein Aigu, French Intensive Renal Network, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

ORCID-Profile: Marie-Sophie Pagniez, Thomas Robert, Laurent Mesnard

Zitieren

APA

Pagniez, M. S., Fages, V., Gatinois, C., Larrue, R., Pottier, N., Laboux, T., Lenain, R., Grunewald, O., Robert, T., Rigothier, C., Mesnard, L., & Glowacki, F. (2025). Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. Nephrology Dialysis Transplantation, 40(8), 1522-1530. https://doi.org/10.1093/ndt/gfaf011

Vancouver

Pagniez MS, Fages V, Gatinois C, Larrue R, Pottier N, Laboux T, et al. Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. Nephrology Dialysis Transplantation. 2025;40(8):1522-1530. doi:10.1093/ndt/gfaf011

BibTeX
@article{Pagniez2025,
  author = {Pagniez, Marie-Sophie and Fages, Victor and Gatinois, Clémence and Larrue, Romain and Pottier, Nicolas and Laboux, Timothée and Lenain, Rémi and Grunewald, Olivier and Robert, Thomas and Rigothier, Claire and Mesnard, Laurent and Glowacki, François},
  title = {Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  volume = {40},
  number = {8},
  pages = {1522--1530},
  doi = {10.1093/ndt/gfaf011}
}
Kostenlos starten →